BNP Paribas Asset Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-23,704
Closed -$836K 853
2023
Q3
$836K Hold
23,704
﹤0.01% 740
2023
Q2
$901K Sell
23,704
-783
-3% -$31.2K ﹤0.01% 735
2023
Q1
$925K Buy
24,487
+2,906
+13% +$112K ﹤0.01% 761
2022
Q4
$915K Sell
21,581
-7,627
-26% -$314K ﹤0.01% 783
2022
Q3
$938K Sell
29,208
-4,232
-13% -$149K ﹤0.01% 765
2022
Q2
$1.09M Buy
33,440
+136
+0.4% +$4.41K ﹤0.01% 770
2022
Q1
$1.21M Sell
33,304
-13,378
-29% -$459K ﹤0.01% 717
2021
Q4
$1.85M Buy
46,682
+7,337
+19% +$306K 0.01% 706
2021
Q3
$1.72M Sell
39,345
-70,638
-64% -$3.17M 0.01% 681
2021
Q2
$4.49M Sell
109,983
-162
-0.1% -$6.25K 0.02% 573
2021
Q1
$3.62M Buy
110,145
+19,083
+21% +$718K 0.01% 578
2020
Q4
$3.7M Buy
+91,062
New +$3.4M 0.02% 547

Other funds holding GMAB

BNP Paribas Asset Management's GMAB Position: Q4 2023 in Review

BNP Paribas Asset Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 23,704 shares — an estimated $836K sold.

BNP Paribas Asset Management first reported a position in GMAB in Q4 2020 and held it in 12 quarters. The position peaked at $4.49M in Q2 2021. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • BNP Paribas Asset Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • BNP Paribas Asset Management sold 23,704 Genmab shares in Q4 2023, an estimated $836K.
  • BNP Paribas Asset Management first reported a position in Genmab in Q4 2020 and held it in 12 quarters.
  • BNP Paribas Asset Management's Genmab position peaked at $4.49M in Q2 2021.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on BNP Paribas Asset Management's 13F filing for Q4 2023, filed 9 Feb 2024.